TWO SIGMA INVESTMENTS, LP - NEOLEUKIN THERAPEUTICS INC ownership

NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 82 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of NEOLEUKIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$175,291
+10.5%
211,194
-6.8%
0.00%
Q1 2023$158,686
+4.3%
226,694
-24.2%
0.00%
Q4 2022$152,209
-30.8%
299,036
-12.9%
0.00%
-100.0%
Q3 2022$220,000
-31.7%
343,136
+9.8%
0.00%0.0%
Q2 2022$322,000
-29.8%
312,473
+28.1%
0.00%0.0%
Q1 2022$459,000
-38.9%
243,970
+56.5%
0.00%
-50.0%
Q4 2021$751,000
-13.6%
155,895
+29.7%
0.00%0.0%
Q3 2021$869,000
+140.7%
120,212
+207.5%
0.00%
+100.0%
Q2 2021$361,000
+97.3%
39,092
+162.6%
0.00%
Q1 2021$183,000
-92.3%
14,887
-91.2%
0.00%
-100.0%
Q4 2020$2,379,000
+35.5%
168,737
+15.3%
0.01%
+16.7%
Q3 2020$1,756,000
+17.3%
146,332
+62.2%
0.01%
-14.3%
Q2 2020$1,497,000
+240.2%
90,204
+133.2%
0.01%
+75.0%
Q1 2020$440,000
+160.4%
38,677
+182.4%
0.00%
+300.0%
Q4 2019$169,000
-10.6%
13,696
-79.4%
0.00%0.0%
Q3 2019$189,00066,3630.00%
Other shareholders
NEOLEUKIN THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,156,200$10,672,0001.77%
ACT CAPITAL MANAGEMENT, LLC 239,000$2,207,0001.13%
EcoR1 Capital, LLC 2,358,804$21,772,0000.81%
Redmile Group, LLC 3,919,235$36,175,0000.54%
Boxer Capital, LLC 1,501,058$13,855,0000.49%
Baker Brothers Advisors 3,821,740$35,275,0000.16%
Sio Capital Management, LLC 38,312$354,0000.09%
Highland Private Wealth Management 46,999$434,0000.06%
PERSONAL CFO SOLUTIONS, LLC 23,710$219,0000.04%
Point72 Asset Management, L.P. 883,102$8,151,0000.04%
View complete list of NEOLEUKIN THERAPEUTICS INC shareholders